Crystallographic fragment screening and deep mutational scanning of Zika virus NS2B-NS3 protease enable development of resistance-resilient inhibitors
Preprint
- 13 February 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
The Zika viral protease NS2B-NS3 is essential for the cleavage of viral polyprotein precursor into individual structural and non-structural (NS) proteins and is therefore an attractive drug target. Generation of a robust crystal system of co-expressed NS2B-NS3 protease has enabled us to perform a crystallographic fragment screening campaign with 1076 fragments. 47 fragments with diverse scaffolds were identified to bind in the active site of the protease, with another 6 fragments observed in a potential allosteric site. To identify binding sites that are intolerant to mutation and thus suppress the outgrowth of viruses resistant to inhibitors developed from bound fragments, we performed deep mutational scanning of NS2B-NS3 protease. Merging fragment hits yields an extensive set of ‘mergers’, defined as synthetically accessible compounds that recapitulate constellations of observed fragment-protein interactions. In addition, the highly sociable fragment hits enable rapid exploration of chemical space via algorithmic calculation and thus yield diverse possible starting points that maximally explore the binding opportunities to NS2B-NS3 protease, facilitating its resistance-resilient antiviral development.Keywords
All Related Versions
- Version 1, 2025-02-13, Research Square
- Published version: Nature Communications, 16 (1), 1.
This publication has 54 references indexed in Scilit:
- Accelerating Drug Discovery With High‐Throughput Crystallographic Fragment Screening and Structural EnablementApplied Research, 2024
- Structure-Based Optimization and Characterization of Macrocyclic Zika Virus NS2B-NS3 Protease InhibitorsJournal of Medicinal Chemistry, 2022
- Characterization of an Allosteric Pocket in Zika Virus NS2B-NS3 ProteaseJournal of Chemical Information and Modeling, 2022
- NS2B‐NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic reviewJournal of Medical Virology, 2021
- Structure‐Based Macrocyclization of Substrate Analogue NS2B‐NS3 Protease Inhibitors of Zika, West Nile and Dengue virusesChemMedChem, 2020
- Crystallographic screening using ultra-low-molecular-weight ligands to guide drug designDrug Discovery Today, 2019
- Association between microcephaly, Zika virus infection, and other risk factors in Brazil: final report of a case-control studyThe Lancet Infectious Diseases, 2018
- Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonistsAntiviral Research, 2017
- One Question, Multiple Answers: Biochemical and Biophysical Screening Methods Retrieve Deviating Fragment Hit ListsChemMedChem, 2015
- Allosteric Inhibition of the NS2B-NS3 Protease from Dengue VirusACS Chemical Biology, 2013